1. Hockenberry M, Wilson D, Winklestein M, Kline NE, eds. Nursing care of infants and children, 7th ed. St. Louis: Mosby, 2003.
2. Ingersoll G. Evaluation of the advance practice nurse role in acute and specialty care. Crit Care Nurs Clin North Am 1995;7:289–299.
3. Christensen J, Akcasu N. The role of the pediatric nurse practitioner in the comprehensive management of pediatric oncology patients in the inpatient setting. J Pediatr Oncol Nurs 1999;16:58–65.
4. Nelms BC. Specialty roles: evolution and challenges. J Pediatr Health Care 2002;16:275–277.
5. Hamric A, Spross J, Hanson J. Advanced nursing practice, 2nd ed. Philadelphia: Saunders, 2000.
6. Hockenberrry-Eaton M. A comparison of the educational needs of advanced practice nurses in pediatric oncology: 1987–1995, commentary. J Pediatr Oncol Nurs 1997;13: 212–213.
7. Hare ML, Hinds PS. Moving the research agenda forward for children and adolescents with cancer. J Pediatr Oncol Nurs 2004;21:121–122.
8. Scope and standards of pediatric oncology nursing practice. Washington, DC: American Nurses Association, 2000.
9. Hedstrom M, Haglund K, Skolin I, Von Essen L. Distressing events for children and adolescents with cancer: child, parent, and nurse perceptions. J Pediatr Oncol Nurs 2003;20: 120–132.
10. Woodgate RL, Degner LF. Expectations and beliefs about children’s cancer symptoms: perspective of children with and their families. Oncol Nurs Forum 2003;30:479–491.
11. Collins JJ, Byrnes MM, Dunkel IJ, et al. The measurement of symptoms in children with cancer. J Pain Symptom Manage 2000;19:363–373.
12. Docherty SL. Symptom experiences of children and adolescents with cancer. Annu Rev Nurs Res 2003;21:123–149.
13. Barbacane JL. Back to the basics: handwashing. Geriat Nurs 2004;25:90–92.
14. Levine JE, Boxer, LA. Clinical application of hematopoietic growth factors in pediatric oncology. Curr Opin Hematol 2002;9:222–227.
15. Report of the committee on infectious diseases, 25th ed. Elk Grove Village, IL: American Academy of Pediatrics, 2000.
16. Carcao MD, Lau RC, Gupta A, et al. Sequential use of intravenous and oral acyclovir in the therapy of varicella in immunocompromised children. Pediatr Infect Dis J 1998;17: 626–631.
17. Schulster L, Chinn, RY. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 2003;52(RR-10):1–42.
18. Centers for Disease Control and Prevention. Outbreak of varicella among vaccinated children-Michican 2003. MMWR 2004;53(18):389–392.
19. Clarke E, Glaser AW, Picton, SV. Pneumocystis carinii pneumonia: a late presentation following treatment for stage IV neuroblastoma. Pediatr Hematol Oncol 2003;20:467–471.
20. Kappagoda C, Shaw P, Burgess M, et al. Varicella vaccine in non-immune household contactw of children with cancer or leukaemia. J Paediatr Child Health 1999;35:341–345.
21. Lee MS, Kim WC. Intracranial hemorrhage associated with idiopathic thrombocytopenic purpura: a report of seven patients and a meta-analysis. Neurology 1998;50:1160–1163.
22. Wazny LD, Ariano RE. Evaluation and management of drug-induced thrombocytopenia in the acutely ill patient. Pharmacotherapy 2000;20:292–307.
23. Pruss A, Kalus U, Radtke H, et al. Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions. Transfus Apheresis Sci 2004;30:41–46.
24. Enright H, Davis K, Gernsheimer T, et al. Factors influencing moderate to severe reactions to platelet transfusions: experience of the TRAP multicenter clinical trial. Transfusion 2003;43:1545–1552.
25. Grass JA, Wafa T, Reames A, et al. Prevention of transfusion-associated graft-versus-host disease by photochemical treatment. Blood 1999;93:3140–3147.
26. James V. Bloody easy: blood transfusions, blood alternatives and transfusion reactions—a guide to transfusion medicine. Transfus Med 2004;14:193–194.
27. Herberg, A. Blood product administration. In: Bowden VR, Smith Greenberg C, eds. Pediatric nursing procedures. Philadelphia: Lippincott Williams & Wilkins, 2003:122–132.
28. Bryant R. Managing side effects of childhood cancer treatment. J Pediatr Nurs 2003;18: 113–125.
29. Andrassy RJ, Chwals WJ. Nutritional support of the pediatric oncology patient. Nutrition 1998;14:124–129.
30. Bodanszky HE. Nutrition and pediatric cancer. Ann N Y Acad Sci 1997;824:205–209.
31. Muscaritoli M, Grieco G, Capria S, et al. Nutritional and metabolic support in patients undergoing bone marrow transplantation. Am J Clin Nutr 2002;75:183–190.
32. Langdana A, Tully N, Molloy E, et al. Intensive enteral nutrition support in paediatric bone marrow transplantation. Bone Marrow Transplant 2001;27:741–746.
33. Pietsch JB, Ford C, Whitlock JA. Nasogastric tube feedings in children with high-risk cancer: a pilot study. J Pediatr Hematol Oncol 1999;21:111–114.
34. DeSwarte-Wallace J, Firouzbakhsh S, Finklestein JZ. Using research to change practice: enteral feedings for pediatric oncology patients. J Pediatr Oncol Nurs 2001;18:217–223.
35. Skolin I, Ulla-Kaisa KH, Wahlin YB. Parents’ perception of their child’s food intake after the start of chemotherapy. J Pediatr Oncol Nurs 2001;18:124–136.
36. Symonds RP. Treatment-induced mucositis: an old problem with new remedies. Br J Cancer 1998;77:1689–1695.
37. Plevova P. Prevention and treatment of chemotherapy- and radiotherapy-induced oral mucositis: a review. Oral Oncol 1999;35:453–470.
38. Miller M, Kearney N. Oral care for patients with cancer: a review of the nursing literature. Cancer Nurs 2001;24:241–254.
39. Rubenstein EB, Peterson DE, Schubert M, et al; Mucositis Study Section of the Multinational Association for Supportive Care in Cancer; International Society for Oral Oncology. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 2004;100[9 Suppl]:2026–2046.
40. Hinds PS, Hockenberry-Eaton M, Quargnenti A, et al. Fatigue in 7- to 12-year-old patients with cancer from the staff perspective: an exploratory study. Oncol Nurs Forum 1999;26:37–45.
41. Hockenberry MJ, Hinds PS, Barrera P, et al. Three instruments to assess fatigue in children with cancer: the child, parent and staff perspectives. J Pain Symptom Manage 2003; 25:319–328.
42. Hockenberry-Eaton M, Hinds PS, Alcoser P, et al. Fatigue in children and adolescents with cancer. J Pediatr Oncol Nurs 1998;15:172–182.
43. Davies B, Whitsett SF, Bruce A, McCarthy P. A typology of fatigue in children with cancer. J Pediatr Oncol Nurs 2002;19:12–21.
44. Varni JW, Burwinkle TM, Katz ER, et al. The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module. Cancer 2002;94:2090–2106.
45. Anand KJ. Clinical importance of pain and stress in preterm neonates. Biol Neonate 1998;73:1–9.
46. Oakes LL. Assessment and management of pain in the critically ill pediatric patient. Crit Care Nurs Clin North Am 2001;13:281–295.
47. American Academy of Pediatrics. The assessment and management of acute pain in infants, children, and adolescents. Pediatrics 2001;108:793–796.
48. Beyer JE, McGrath PJ, Berde CB. Discordance between self-report and behavioral pain measures in children aged 3–7 years after surgery. J Pain Symptom Manage 1990;5:350–356.
49. Hockenberry-Eaton M, Barrera P, Brown M, et al. Pain Management in children with cancer. Austin, TX: Texas Cancer Council, 1999.
50. Ferrell BR, Rhiner M, Shapiro B, Dierkes M. The experience of the pediatric cancer pain. Part I. Impact of pain on the family. J Pediatr Nurs 1994;9:368–379.
51. Ferrell BR, Rhiner M, Shapiro B, Strause L. The family experience of cancer pain management in children. Cancer Pract 1994;2:441–446.
52. Piaget J. The theory of stages in cognitive development. New York: McGraw-Hill, 1969.
53. Broome ME, Rehwaldt M, Fogg L. Relationships between cognitive behavioral techniques, temperament, observed distress, and pain reports in children and adolescents during lumbar puncture. J Pediatr Nurs 1998;13:48–54.
54. Zeltzer LK, Jay SM, Fisher DM. The management of pain associated with pediatric procedures. Pediatr Clin North Am 1989;36:941–964.
55. Leahy S, Hockenberry-Eaton M, Sigler-Price K. Clinical management of pain in children with cancer. Cancer Practice 2(1):37–45.
56. Holdsworth MT, Raisch DW, Winter SS, et al. Pain and distress from bone marrow aspiration and lumbar punctures. Ann Pharmacother 2003;37:17–22.
57. Bradlyn AS, et al. Children’s reactions to invasive medical procedures: the potential importance of procedure, age, and physical restraint. J Psychosoc Oncol 1993;11:70.
58. Conte PM, Walco GA, Sterling CM, et al. Procedural pain management in pediatric oncology: a review of the literature. Cancer Invest 1999;17:448–459.
59. Weisman SJ, Bernstein B, Schechter NL. Consequences of inadequate analgesia during painful procedure in children. Arch Pediatr Adolesc Med 1998;152:147–149.
60. Ljungman G, Gordh T, Sorensen S, Kkreuger A. Pain in paediatric oncology: interviews with children, adolescent and their parents. Acta Paediatr 1999;88:623–630.
61. Crock C, Olsson C, Phillips R, et al. General anaesthesia or conscious sedation for painful procedures in childhood cancer: the family’s perspective. Arch Dis Child 2003;88: 253–257.
62. Hain RD, Campbell C. Invasive procedures carried out in conscious children: contrast between North American and European paediatric oncology centres. Arch Dis Child 2001;85:12–15.
63. Jayabose S, Levendoglu-Tugal O, Giamelli J, et al. Intravenous anesthesia with propofol for painful procedures in children with cancer. J Pediatric Hem Oncol 2001;23:290–293.
64. Ljungman G, Gordth T, Sorensen S, Kreuger A. Lumbar puncture in pediatric oncology: conscious sedation vs. general anesthesia. Med Pediatr Oncol 2001;36:372–379.
65. Chen E, Craske MG, Katz ER, et al. Pain-sensitive temperament: does it predict procedural distress and response to psychological treatment among children with cancer? J Pediatr Psychol 2000;25:269–278.
66. Schecter N, Altman A, Weisman S. Report of the consensus conference on the management of pain in childhood cancer. Pediatrics 1990;86:813.
67. Agency for Health Care Policy and Research. Acute pain management in infants, children and adolescents: operative and medical procedures. Quick reference guide for clinicians. Washington, DC: US Department of Health and Human Services, 1992.
68. Macpherson CF, Lundblad LA. Conscious sedation of pediatric oncology patients for painful procedures: development and implementation of a clinical practice protocol. J Pediatr Oncol Nurs 1997;14:33–42.
69. Tyc VL, Bieberich AA, Hinds P, Sifford L. A survey of pain services for pediatric oncology patients: their composition and function. J Pediatri Oncol Nurs 1998;15:207–215.
70. Luhman J, Hurt S, Shootman, M, Kennedy, R. A comparison of buffered lidocaine versus ELA-Max before peripheral intravenous catheter insertions in children. Pediatr 2004;113(3 Pt 1):e217–220.
71. Koh JL, Fanurik D, Stoner PD, et al. Efficacy of parental application of eutectic mixture of local anesthetics for intervenous insertion. Pediatrics 1999;103:e79.
72. Riendeau LA, Bennett D, Black-Noller G, et al. Evaluation of the analgesic efficacy of EMLA cream in volunteers with differing skin pigmentation undergoing venipuncture. Reg Anesth Pain Med 1999;24(2):165–169.
73. Vincent C, Denyes MJ. Relieving children’s pain: nurses’ abilities and analgesic administration practices J Pediatr Nurs 2004;19:40–50.
74. Van Cleve L, Bossert, E, Beecroft, P, et al. The pain experience of children with leukemia during the first year after diagnosis. Nurs Res 2004;53:1–10.
75. Koscielniak-Nielsen Z, Hesselbjerg L, Brushoj J, et al. EMLA a patch for spinal puncture. A comparison of EMLA patch with lignocaine infiltration of placebo patch. Anaesthesia 1998;53:1218–1222.
76. Juarez Gimenez JC, Oliveras M, Hidalgo E, et al. Anesthetic efficacy of eutectic prilocaine-lidocaine cream in pediatric oncology patients undergoing lumbar puncture. Ann Pharmacother 1996;30:1235–1237.
77. McGrath PA. Development of the World Health Organization guidelines on cancer pain relief and palliative care in children. J Pain Symptom Manage 1996;12:87–92.
78. Cheong K, Perry D, Karapetis C, Koczwara B. High rate of complications associated with peripherally inserted central venous catheters in patients with solid tumors. Intern Med 2004;34:234–238.
79. Hadaway LC. Breakthroughs in vascular access. Nurs Manage 2000;31(12):45–46.
80. Staumou SC, Maltezou HD, Pourtsidis A, et al. Hickman-Broviac catheter-related infections in children with malignancies. Mt Sinai J Med 1999;66:320–326.
81. Peterson KK. Central line sepsis. Clin J Oncol Nurs 2003;7:218–221, 241.
82. Hachem R, Raad I. Prevention and management of long-term catheter related infections in cancer patients. Cancer Invest 2002;20:1105–1113.
83. Kline NE, Ecktenkamp D, Harley J, et al. Chemotherapy provider program curriculum. Glenview, IL: Association of Pediatric Oncology Nurses, 2004.
84. Kassner E. Evaluation and treatment of chemotherapy extravasation injuries. J Pediatr Oncol Nurs 2000;17:135–148.
85. Allbanell J, Baselga J. Systemic therapy emergencies. Semin Oncol 2000;27:347–361.
86. Cincotta N. Pschosocial issues in the world of children with cancer. Cancer 1993;71 [Suppl]:3251–3260.
87. McCarthy AM, Williams J, Plumer C. Evaluation of a school re-entry nursing intervention for children with cancer. J Pediatr Oncol Nurs 1998;15:143–152.
88. Schwartz CL. Long-term survivors of childhood cancer: the late effects of therapy. Oncologist 1999;4:45–54.
89. Hockenberry-Eaton M. Essentials of pediatric oncology nursing. Glenview, IL: Association of Pediatric Oncology Nurses, 1998.
90. Hobbie W, Hollen PJ. Pediatric nurse practitioners specializing with survivors of childhood cancer. J Pediatr Health Care 1993;7:24–30.
91. Sklar CA. Overview of the effects of cancer therapies: the nature, scale an breadth of the problem. Acta Paediatr Suppl 1999;88(433):1–4.
92. Grenier MA, Lopshultz SE. Epidemiology of anthracycline cardiotoxicity in children and adults. Semin Oncol 1998;25[4 Suppl 10]:72–85.
93. Raney B, Heyn R, Cassady R, Marks LB. Late effects of cancer therapy of the genitourinary tract in children. In: Schwartz CL, Hobbie WL, Constine LS, Ruccione KS, eds. Survivors of childhood cancer. St. Louis: Mosby-Year Book, 1994:245–262.
94. Cerveri I, Zoia MC, Fulgoni P, et al. Late pulmonary sequelae after childhood bone marrow transplantation. Thorax 1999;54:131–135.
95. Blatt J, Neigut D, Robertson JM, Lawrence TS. Late gastrointestinal and hepatic effects. In: Schwartz CL, Hobbie WL, Constine LS, Ruccione KS, eds. Survivors of childhood cancer. St. Louis: Mosby-Year Book, 1994:197–212.
96. Donaldson SS. Effects of irradiation of skeletal growth and development. In: Green DM, Dangio GJ, eds. Late effects of treatment for childhood cancer. New York: Wiley-Liss, 1992:63–70.
97. Anderson VA, Godber T, Smibert E, et al. Cognitive and academic outcome following cranial irradiation and chemotherapy in children: a longitudinal study. Br J Cancer 2000;82:255–262.
98. Brown RT, Madan-Swain A, Walco GA, et al. Cognitive and academic late effects among children previously treated for acute lymphocytic leukemia receiving chemotherapy as CNS prophylaxis. J Pediatr Psychol 1998;23:333–340.
99. Moore IM, Packer RJ, Karl D, Bleyer WA. Adverse effects of cancer treatment on the central nervous system. In: Schwartz CL, Hobbie WL, Constine LS, Ruccione KS, eds. Survivors of childhood cancer. St. Louis: Mosby-Year Book, 1994:81–96.
100. Sklar CA. Neuroendocrine complications of cancer therapy. In: Schwartz CL, Hobbie WL, Constine LS, Ruccione KS, eds. Survivors of childhood cancer. St. Louis: Mosby-Year Book, 1994: 97–110.
101. Cohen A, Rovelli R, Zecca S, et al. Endocrine late effects in children who underwent bone marrow transplantation: review. Bone Marrow Transplant 1998;21[Suppl 2]:S64–67.
102. Bottomley SJ, Kassner E. Late effects of childhood cancer therapy. J Pediatr Nurs 2003; 18:126–1333.